Journal of Hematology & Oncology | Most Viewed

Submit a manuscript Register Follow us on

Explore journal

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 1069 Accesses	Review Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options Gerhard J Molderings, Stefan Brettner, Jürgen Homann, Lawrence B Afrin Journal of Hematology & Oncology 2011, 4:10 (22 March 2011) Abstract \| Full text \| PDF \| PubMed
	2. 864 Accesses	Review Clinical applications of mesenchymal stem cells Shihua Wang, Xuebin Qu, Robert Chunhua Zhao Journal of Hematology & Oncology 2012, 5:19 (30 April 2012) Abstract \| Provisional PDF \| PubMed
	3. 770 Accesses	Review Recent advances and novel agents for gastrointestinal stromal tumor (GIST) Gurpreet Lamb, Samir Ambrale, Byung Lee, Ridhi Gupta, Shamudheen M Rafiyath, Delong Liu Journal of Hematology & Oncology 2012, 5:21 (8 May 2012) Abstract \| Provisional PDF \| PubMed
	4. 724 Accesses	Research Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells Chaoquan Hu, Limin Huang, Caroline Gest, Xiaodong Xi, Anne Janin, Claudine Soria, Hong Li, He Lu Journal of Hematology & Oncology 2012, 5:16 (25 April 2012) Abstract \| Provisional PDF \| PubMed
	5. 585 Accesses	Review The effects of β-glucan on human immune and cancer cells Godfrey Chan, Wing Chan, Daniel Sze Journal of Hematology & Oncology 2009, 2:25 (10 June 2009) Abstract \| Full text \| PDF \| PubMed
	6. 481 Accesses	Research Deprivation of arginine by recombinant human arginase in prostate cancer cells Eddy C Hsueh, Stephanie M Knebel, Wai-Hung Lo, Yun-Chung Leung, Paul Ning-Man Cheng, Chung-Tsen Hsueh Journal of Hematology & Oncology 2012, 5:17 (30 April 2012) Abstract \| Provisional PDF \| PubMed
	7. 453 Accesses	Research Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) Azra Raza, Naomi Galili, Deborah Mulford, Scott E. Smith, Gail Brown, David P. Steensma, Roger M. Lyons, Ralph Boccia, Mikkael A. Sekeres, Garcia-Manero Guillermo, Ruben A. Mesa Journal of Hematology & Oncology 2012, 5:18 (30 April 2012) Abstract \| Provisional PDF \| PubMed
	8. 432 Accesses	Review Mechanism of action of lenalidomide in hematological malignancies Venumadhav Kotla, Swati Goel, Sangeeta Nischal, Christoph Heuck, Kumar Vivek, Bhaskar Das, Amit Verma Journal of Hematology & Oncology 2009, 2:36 (12 August 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	9. 369 Accesses	Research Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome Naomi Galili, Pablo Tamayo, Olga B Botvinnik, Jill P Mesirov, Margarita R Brooks, Gail Brown, Azra Raza Journal of Hematology & Oncology 2012, 5:20 (6 May 2012) Abstract \| Provisional PDF \| PubMed
	10. 338 Accesses	Review First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib Guoqing Wei, Shamudheen Rafiyath, Delong Liu Journal of Hematology & Oncology 2010, 3:47 (26 November 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	11. 291 Accesses	Review Novel therapeutic agents for cutaneous T-Cell lymphoma Salvia Jain, Jasmine Zain, Owen O'Connor Journal of Hematology & Oncology 2012, 5:24 (17 May 2012) Abstract \| Provisional PDF \| PubMed
	12. 324 Accesses	Review Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP Yuan Yuan, Yu-Min Liao, Chung-Tsen Hsueh, Hamid R Mirshahidi Journal of Hematology & Oncology 2011, 4:16 (20 April 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	13. 299 Accesses	Short report Pharmacokinetics of Dasatinib for Philadelphia- Positive Acute Lymphocytic Leukemia with Acquired T315I mutation Naoto Takahashi, Masatomo Miura, Stuart A Scott, Takenori Niioka, Kenichi Sawada Journal of Hematology & Oncology 2012, 5:23 (15 May 2012) Abstract \| Provisional PDF \| PubMed
	14. 335 Accesses	Review Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs Subhash Padhye, Aamir Ahmad, Nikhil Oswal, Fazlul H Sarkar Journal of Hematology & Oncology 2009, 2:38 (2 September 2009) Abstract \| Full text \| PDF \| PubMed
	15. 334 Accesses	Review The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer Catherine Labbaye, Ugo Testa Journal of Hematology & Oncology 2012, 5:13 (27 March 2012) Abstract \| Full text \| PDF \| PubMed
	16. 283 Accesses	Review Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go Meng Lv, Xiao-Jun Huang Journal of Hematology & Oncology 2012, 5:10 (18 March 2012) Abstract \| Full text \| PDF \| PubMed
	17. 283 Accesses	Case report Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature Utkarsh Acharya, Jen-Tzer Gau, William Horvath, Paolo Ventura, Chung-Tsen Hsueh, Wayne Carlsen Journal of Hematology & Oncology 2008, 1:26 (18 December 2008) Abstract \| Full text \| PDF \| PubMed
	18. 279 Accesses	Review Current findings for recurring mutations in acute myeloid leukemia Shinichiro Takahashi Journal of Hematology & Oncology 2011, 4:36 (14 September 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	19. 272 Accesses	Research R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature Ganguly Siddhartha, Patel Vijay Journal of Hematology & Oncology 2009, 2:14 (24 March 2009) Abstract \| Full text \| PDF \| PubMed
	20. 257 Accesses	Review ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside Jianbiao Zhou, Boon-Cher Goh, Daniel H Albert, Chien-Shing Chen Journal of Hematology & Oncology 2009, 2:33 (30 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	21. 237 Accesses	Rapid communication The significance of low PU.1 expression in patients with acute promyelocytic leukemia Xuehua Zhu, Hui Zhang, Maoxiang Qian, Xujie Zhao, Wentao Yang, Ping Wang, Ji Zhang, Kankan Wang Journal of Hematology & Oncology 2012, 5:22 (8 May 2012) Abstract \| Provisional PDF \| PubMed
	22. 260 Accesses	Review Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases Véronique Gelsi-Boyer, Mandy Brecqueville, Raynier Devillier, Anne Murati, Marie-Joelle Mozziconacci, Daniel Birnbaum Journal of Hematology & Oncology 2012, 5:12 (21 March 2012) Abstract \| Full text \| PDF \| PubMed
	23. 239 Accesses	Review The Four types of Tregs in malignant lymphomas Jing Wang, Xiao-Yan Ke Journal of Hematology & Oncology 2011, 4:50 (9 December 2011) Abstract \| Full text \| PDF \| PubMed
	24. 242 Accesses	Research Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function Wing Chan, Christopher Cheung, Helen Law, Yu Lau, Godfrey Chan Journal of Hematology & Oncology 2008, 1:9 (21 July 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	25. 240 Accesses	Review Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy RuiRong Yuan, Andrea Kay, William J Berg, David Lebwohl Journal of Hematology & Oncology 2009, 2:45 (27 October 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central